News

Recommended management of asthma, including appropriate diagnostic steps and use of fractional exhaled nitric oxide (FeNO) in ...
Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...
Asthma isn’t all about medication, as it’s also about having a healthy and safe environment, both inside and outside. From ...
Women working permanent night shifts vs. day shifts faced an elevated likelihood for moderate to severe asthma, whereas this was not observed in men, according to results published in ERJ Open ...
Discover how urban environments create distinct asthma phenotypes and which city triggers are causing the most breathing ...
Sensitive populations, such as those with asthma, respiratory issues, or heart disease, should take precautions.
New specialized treatment center offers comprehensive care for those struggling with persistent breathing difficulties.
Biological drugs have been a game-changer for people with severe asthma, helping them breathe easier and live more ...
The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...
Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its ...
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline ...
This updated asthma guideline establishes a consistent approach to improving asthma diagnosis and control in adults and ...